Ravi Ramjeesingh

Involvement of Integrin α_vβ₃and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells

Evelyn B. Voura, Ravi Ramjeesingh, Anthony M.P. Montgomery et al. · Molecular Biology of the Cell · 2001 · 199 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +13

The CCTG PA.7 phase II trial of gemcitabine and nab-paclitaxel with or without durvalumab and tremelimumab as initial therapy in metastatic pancreatic ductal adenocarcinoma

Daniel J. Renouf, Jonathan M. Loree, Jennifer J. Knox et al. · Nature Communications · 2022 · 139 citations · Full text

Medicine, Oncology, Pharmacology +17

The Apical Na+/H+ Exchanger Isoform NHE3 Is Regulated by the Actin Cytoskeleton

Kazuyoshi Kurashima, Sudhir J.A. D’Souza, Katalin Szászi et al. · Journal of Biological Chemistry · 1999 · 116 citations · Full text

Life Sciences, Biochemistry, Physiology +15

Interleukin‐8 secreted by endothelial cells induces Chemotaxis of melanoma cells through the chemokine receptor CXCR1

Ravi Ramjeesingh, Randy Leung, Chi‐Hung Siu · The FASEB Journal · 2003 · 79 citations

Life Sciences, Immunology, Oncology +17

LBA65 The Canadian Cancer Trials Group PA.7 trial: Results of a randomized phase II study of gemcitabine (GEM) and nab-paclitaxel (Nab-P) vs GEM, nab-P, durvalumab (D) and tremelimumab (T) as first line therapy in metastatic pancreatic ductal adenocarcinoma (mPDAC)

D. J. Renouf, Jennifer J. Knox, Petr Kavan et al. · Annals of Oncology · 2020 · 40 citations

Medicine, Oncology, Pharmacology +14